company_name,website_timestamp,preclinical_stage,molecule,target,target_type,theraputic_area,classification,small_molecules,small_molecules_keyword,small_molecules_source_url,peptides,peptides_keyword,peptides_source_url,proteins,proteins_keyword,proteins_source_url,antibodies,antibodies_keyword,antibodies_source_url,antibody_conjugates,antibody_conjugates_keyword,antibody_conjugates_source_url,fusion_proteins,fusion_proteins_keyword,fusion_proteins_source_url,nucleic_acid_therapeutics,nucleic_acid_therapeutics_keyword,nucleic_acid_therapeutics_source_url,gene_cell_therapies,gene_cell_therapies_keyword,gene_cell_therapies_source_url,vaccines,vaccines_keyword,vaccines_source_url,protein_degraders,protein_degraders_keyword,protein_degraders_source_url,other_modalities,other_modalities_keyword,other_modalities_source_url
aurigene oncology,Error: can't compare offset-naive and offset-aware dateti,Yes,AUR103,CD47,Immune checkpoint protein,Not specified,Small molecule inhibitor,Yes,Small Molecules,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,Yes,Peptides and Peptidomemitics,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,No,,,Yes,Antibodies,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,No,,,No,,,No,,,Yes,CAR-T cell therapy,https://www.aurigene.com/,No,,,Yes,Targeted protein Degradation,https://www.ambitionbox.com/overview/aurigene-discovery-technologies-overview,No,,
bharat biotech,16-10-2025 06:32,Yes,altSonflex1-2-3,"Shigella O Antigens (S. sonnei, S. flexneri 1b, 2a, and 3a)",Bacterial outer membrane antigens,Not specified,GMMA-based vaccine (Generalized Modules for Membrane Antigens),No,,,No,,,Yes,recombinant Streptokinase,https://dcvmn.org/member/bharat/,No,,,No,,,No,,,No,,,No,,,Yes,"vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika, Cholera, and the worldâ€™s first tetanus-toxoid conjugated vaccine for Typhoid",https://dcvmn.org/member/bharat/,No,,,No,,
23 century clinic,16-10-2025 05:36,No,RNDP-001,Dopamine Neuron Progenitor,Cell Therapy,Not specified,iPSC-derived cell replacement therapy,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,stem cell therapy,https://23cbio.com/,No,,,No,,,No,,
nexcella inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cirm.ca.gov', port=4",Yes,NXC-201,BCMA (B-cell maturation antigen),Receptor,Not specified,CAR-T cell therapy,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR-T NXC-201,https://www.cgtlive.com/view/immix-nexcella-make-progress-us-trial-light-chain-amyloidosis-car-t-nxc-201,No,,,No,,,No,,
targazyme inc,10-10-2023 06:40,No,TZ 101,Not specified,Not specified,Not specified,cell therapy,Yes,small molecule products (TZ101 and TZ102),https://www.linkedin.com/company/targazyme,No,,,Yes,clinical-grade fucosyltransferase enzymes,https://www.linkedin.com/company/targazyme,No,,,No,,,No,,,No,,,Yes,"cell therapy, gene therapy and regenerative medicine",https://www.linkedin.com/company/targazyme,No,,,No,,,No,,
shenzhen pregene biopharma co ltd,06-04-2022 08:30,Yes,CT053,CD19,Receptor,Not specified,CAR-T therapy,No,,,No,,,No,,,Yes,Nanobody Screening Platform,http://en.pregene.com/,No,,,No,,,No,,,Yes,Developing urgently needed cell and gene therapy drugs for clinical treatment,http://en.pregene.com/,No,,,No,,,No,,
biotherapy services ltd,2025-09-24 00:00:00,No,ZORYVE (roflumilast),Phosphodiesterase 4 (PDE4),Enzyme,Not specified,Topical PDE4 inhibitor,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,autologous regenerative therapies,https://www.icfg.net/transactions/biotherapy-services-ltd/,No,,,No,,,No,,
carsgen therapeutics ltd,2025-08-14 20:15:00,Yes,Zevorcabtagene Autoleucel,Not specified,Not specified,Not specified,CAR-T therapy,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR T-cell therapies,https://www.prnewswire.com/news-releases/carsgen-therapeutics-announces-2025-interim-results-302529973.html,No,,,No,,,No,,
